| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma (NCT07741877) | Iovance Biotherapeutics, Inc. | 2026-09-01 |
| A Study of IOV-5001 in Adults With Advanced Solid Tumors (NCT07743723) | Iovance Biotherapeutics, Inc. | 2026-08-01 |
| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma (NCT07288203) | Iovance Biotherapeutics, Inc. | 2025-11-28 |
| A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel (NCT06940739) | Iovance Biotherapeutics, Inc. | 2025-03-11 |
| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. (NCT06481592) | Iovance Biotherapeutics, Inc. | 2024-10-29 |
| Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants (NCT06566092) | Iovance Biotherapeutics, Inc. | 2024-03-28 |
| Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. (NCT05727904) | Iovance Biotherapeutics, Inc. | 2023-03-30 |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer (NCT05361174) | Iovance Biotherapeutics, Inc. | 2022-07-20 |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer (NCT04614103) | Iovance Biotherapeutics, Inc. | 2021-05-07 |
| Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL (NCT04155710) | Iovance Biotherapeutics, Inc. | 2020-02-19 |
| Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors (NCT03645928) | Iovance Biotherapeutics, Inc. | 2019-05-07 |
| Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer (NCT03419559) | Iovance Biotherapeutics, Inc. | 2018-02-28 |
| Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma (NCT03108495) | Iovance Biotherapeutics, Inc. | 2017-06-22 |
| Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck (NCT03083873) | Iovance Biotherapeutics, Inc. | 2017-01-09 |
| Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma (NCT02360579) | Iovance Biotherapeutics, Inc. | 2015-09-24 |
| Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release (NCT05398640) | Iovance Biotherapeutics, Inc. | |